1Ho A, Magder LS, Barr SG, et al. Decreases in anti-doublestranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum, 2001,44: 2342-2349. 被引量：1
2Illei GG, Tackey E, Lapteva L, et al. Biomarkers in systemic lupus erythematosus(Ⅰ): general overview of biomarkers and their applicability. Arthritis Rheum, 2004, 50: 1709-1720. 被引量：1
3Nagy G, Brozik M, Tornoci L, et al. Diagnostic value of combined evaluation of neopterin and anti-DNA antibody levels for assessment of disease activity in systemic lupus erythematosus. Clin Exp Rheumatol, 2000, 18: 699-705. 被引量：1
4Mollnes TE, Haga H J, Brun JG, et al. Complement activation in patients with systemic lupus erythematosus without nephritis.Rheumatology (Oxford), 1999, 38: 933-940. 被引量：1
5Andersen LS, Petersen J, Svenson M, et al. Production of IL-1β,IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity, 1999, 30: 235-242. 被引量：1
6Dejica D. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases: effect of immunosuppressive therapy. Roum Arch Microbiol Immunol, 2001, 60: 183-201. 被引量：1
7Nishitani Y, Kubo A, Iwano M, et al. Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis. Clin Exp Immunol, 2001, 124: 330-336. 被引量：1
8Yin Z, Bahtiyar G, Zhang N, et al. IL-10 regulates murine lupus.J Immunol, 2002, 169: 2148-2155. 被引量：1
9Amerio P, Frezzolini A, Abeni D, et al. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1,Th-2, pro-inflammatory cytokines and disease activity: IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol, 2002, 20: 535-538. 被引量：1
10Aringer M, Feierl E, Steiner G, et al. Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death.Lupus, 2002, 11: 102-108. 被引量：1
3Benueci M ,Gobbi FL,Del-Rosso A,et al. Disease activity and antinucleosome antibodies in systemic lupus erythernatosus[J].Scand J Rheumatol, 2003,32 (1):42-45. 被引量：1
4Bluestein H. Neuropsychiatric disorders of SLE. In: Lahita RD, ed. Systemic lupus erythematosus [M]. 2nd. New York : Academic Press, 1992 : 639-656. 被引量：1
5Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40(1):1725. 被引量：1
9Benucci M, Gobbi FL, del Rosso A, et al. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol, 2003, 32: 42-45. 被引量：1
10Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725. 被引量：1
